The Impact of Previous Catheter-Based Ablation on the Efficacy of the Cox-Maze IV Procedure Shoichi Okada, MD, Timo Weimar, MD, Marc R. Moon, MD, Richard B. Schuessler, PhD, Laurie A. Sinn, RN, BSN, Ralph J. Damiano, MD, Hersh S. Maniar, MD The Annals of Thoracic Surgery Volume 96, Issue 3, Pages 786-791 (September 2013) DOI: 10.1016/j.athoracsur.2013.04.071 Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Right atrial lesion set. The Annals of Thoracic Surgery 2013 96, 786-791DOI: (10.1016/j.athoracsur.2013.04.071) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Left atrial lesion set. The Annals of Thoracic Surgery 2013 96, 786-791DOI: (10.1016/j.athoracsur.2013.04.071) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 (A) Freedom from atrial fibrillation at 3, 6, and 12 months. (B) Freedom from atrial fibrillation and antiarrhythmic drugs at 3, 6, and 12 months. *p > 0.1. (NA = patients who were previously never ablated; PCBA = patients with previous catheter ablation.) The Annals of Thoracic Surgery 2013 96, 786-791DOI: (10.1016/j.athoracsur.2013.04.071) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions